FindTrial
Sign In

Among non-IVF patients undergoing ovulation induction with clomiphene citrate (Clomid® 50 mg) and having no reaction at day 13 of the cycle, does administration of an increased dose of clomiphene citrate (Clomid® 100 mg) compared with gonadotropins, achieve similar rates of folliculogenesis?

Among non-IVF patients undergoing ovulation induction with clomiphene citrate (Clomid® 50 mg) and having no reaction at day 13 of the cycle, does administration of an increased dose of clomiphene citrate (Clomid® 100 mg) compared with gonadotropins, achieve similar rates of folliculogenesis?

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-006372-29-BE
Enrollment
40
Registered
2008-11-18
Start date
2008-11-28
Completion date
Unknown
Last updated
2014-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The purpose of the present study is to analyse prospectively if highly purified hMG compared with increased dose of clomiphene citrate has different outcomes in folliculogenesis in ovulation induction cycles.

Interventions

Trade Name: Clomid Product Name: Clomid Product Code: CC Pharmaceutical Form: Capsule*

Sponsors

Blockeel Christophe
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: =65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: = 39 years old on day of randomisation

Design outcomes

Primary

MeasureTime frame
Main Objective: The purpose of the present study is to analyse prospectively if highly purified hMG compared with increased dose of clomiphene citrate has different outcomes in folliculogenesis in ovulation induction cycles. The primary endpoint of the study is the folliculogenesis in each treatment group.;Secondary Objective: The secondary endpoint is the pregnancy rate in each treatment group.;Primary end point(s): Folliculogenesis in each treatment group—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026